Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,067,988
in 15 filings, $36.6M under 10b5-1 plans

Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MAHONEY DAVID L −$12.3M Director sold 8% of stake
  2. Maduck Sean −$11.7M See Remarks sold 91% of stake
  3. Vieira Roberto Wandenkolk −$8.1M President, Oncology sold 95% of stake
  4. Park Kimberly −$3.3M Director sold 100% of stake
  5. Lyon Joseph Douglas −$2.3M See Remarks sold 78% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-01 Maduck Sean See Remarks Grant or award 10b5-1 +582 $25.97 $15K 73,873
2023-12-01 Maduck Sean See Remarks Grant or award 10b5-1 +582 74,455
2023-12-01 Maduck Sean See Remarks Option exercise · Stock option (right to buy) 10b5-1 −10,009 10,000
2023-12-01 Maduck Sean See Remarks Option exercise · Stock option (right to buy) 10b5-1 −14,991 16,986
2023-12-01 Guyer William Chief Development Officer Grant or award +609 $25.97 $16K 6,034
2023-12-01 Guyer William Chief Development Officer Grant or award +609 6,643
2023-12-01 Mokari Atabak Chief Financial Officer Grant or award +508 $25.97 $13K 8,437
2023-12-01 Mokari Atabak Chief Financial Officer Grant or award +508 8,945
2023-12-01 Robb Gary Charles Chief Business Officer Grant or award +638 $25.97 $17K 22,133
2023-12-01 Robb Gary Charles Chief Business Officer Grant or award +638 22,771
2023-11-13 WILSON JAMES N Director Gift −3,000 1,316,026
2023-11-02 Lyon Joseph Douglas Chief Accounting Officer Option exercise 10b5-1 +3,977 $11.35 $45K 9,831
2023-11-02 Lyon Joseph Douglas Chief Accounting Officer Sale 10b5-1 −3,977 $28.11 $112K 5,854
2023-11-02 Lyon Joseph Douglas Chief Accounting Officer Option exercise · Stock option (right to buy) 10b5-1 −3,977 49,167
2023-11-02 Maduck Sean See Remarks Option exercise 10b5-1 +19,888 $2.61 $52K 93,179
2023-11-02 Maduck Sean See Remarks Sale 10b5-1 −19,888 $28.11 $559K 73,291
2023-11-02 Maduck Sean See Remarks Option exercise · Stock option (right to buy) 10b5-1 −19,888 20,009
2023-11-01 Lyon Joseph Douglas Chief Accounting Officer Option exercise 10b5-1 +1,023 $11.35 $12K 6,877
2023-11-01 Lyon Joseph Douglas Chief Accounting Officer Sale 10b5-1 −1,023 $28.08 $29K 5,854
2023-11-01 Lyon Joseph Douglas Chief Accounting Officer Option exercise · Stock option (right to buy) 10b5-1 −1,023 53,144

Page 45 of 61 · 1,220 trades